Bullseye Asset Management LLC Liquidia Corp Transaction History

Bullseye Asset Management LLC

  • $217 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 12, 2020
SELL
$4.34 - $8.28 $320,183 - $610,857
-73,775 Closed
0 $0
Q2 2020

Aug 11, 2020
BUY
$4.86 - $11.44 $85,438 - $201,115
17,580 Added 31.28%
73,775 $621,000
Q1 2020

May 08, 2020
SELL
$3.31 - $7.15 $791 - $1,708
-239 Reduced 0.42%
56,195 $265,000
Q4 2019

Feb 18, 2020
BUY
$3.07 - $5.11 $173,252 - $288,377
56,434 New
56,434 $241,000

Others Institutions Holding LQDA

# of Institutions
171
Shares Held
44.3M
Call Options Held
1.55M
Put Options Held
1.52M
View Full List

About Liquidia Corp

LQDA Quotes by TradingView
  • Ticker LQDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,362,300
  • Market Cap $710M
  • Description
  • Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...
More about LQDA
Track This Portfolio

Track Bullseye Asset Management LLC Portfolio

Follow Bullseye Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bullseye Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bullseye Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email